Adagene
ADAG
#9329
Rank
NZ$0.16 B
Marketcap
NZ$3.41
Share price
-1.01%
Change (1 day)
-1.35%
Change (1 year)

Revenue for Adagene (ADAG)

Revenue in 2024: NZ$0.17 Million

According to Adagene's latest financial reports the company's current revenue (TTM ) is NZ$0.17 Million. In 2024 the company made a revenue of NZ$0.17 Million a decrease over the revenue in the year 2023 that were of NZ$31.37 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adagene from 2018 to 2024

Annual revenue

Year Revenue Change
2024NZ$0.17 M-99.43%
2023NZ$31.37 M94.9%
2022NZ$16.09 M-8.67%
2021NZ$17.62 M1351.71%
2020NZ$1.21 M46.02%
2019NZ$0.83 M-68.24%
2018NZ$2.61 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
NZ$1.11 B 622,229.56% Jersey
Novavax
NVAX
NZ$1.77 B 992,429.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
NZ$0.24 M 39.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
NZ$37.83 M 21,061.00%๐Ÿ‡ฌ๐Ÿ‡ง UK